Sun Genomics AI Market Strategy report — Gut Health & Probiotics

Answer Capsule

Sun Genomics has essentially no measurable recommendation presence in the May 2026 public packet. Across the surfaced company metrics, it records zero positive mentions, zero valid recommendations, zero top-three placements, zero rank-one placements, and zero modeled captured recommendation value. The clearest weakness is not weak conversion. It is near-total absence from the shortlist. The clearest opportunity is to move Sun Genomics from non-participant to recommendation-eligible in discovery prompts before worrying about comparison or pricing performance.

Request an AI Visibility Audit

Want this analysis for your company? CiteWorks Studio produces AI Market Strategy reports showing where your brand appears, disappears, or gets recommended across ChatGPT, Gemini, Copilot, Perplexity, Google AI Mode, and Google AI Overviews. \[Internal CTA placeholder: Request an AI Visibility Audit\]

Who This Report Is For

This report is for founders, CMOs, ecommerce leaders, agency partners, and communications teams in gut health and probiotics who need to understand whether AI systems recognize Sun Genomics at all during buyer-choice moments.

Report Card

• Report type: AI Market Strategy report
• Target company: Sun Genomics
• Category / market studied: Gut Health & Probiotics
• Reporting month: May 2026
• AI platforms tracked: 6
• Public high-intent clusters: 3
• AI observations analyzed: 642
• Competitors tracked: Align Probiotics, Arrae, Bio-Kult, Culturelle, Florastor, Garden of Life, Pendulum, Renew Life, Seed Health.

Executive Summary

Sun Genomics is effectively absent from the public packet. The surfaced company metrics show zero positive mentions, zero valid recommendations, zero top-three placements, zero rank-one placements, a net sentiment score of zero, and zero modeled monthly captured recommendation value. That is the core finding: Sun Genomics is not just underperforming. It is largely not entering AI recommendation behavior at all in the tracked public prompt set.

The biggest issue is visibility failure rather than recommendation-quality failure. For brands like Renew Life, Pendulum, Align, or Seed, the question is often whether AI systems rank them high enough. For Sun Genomics, the packet shows almost no evidence that AI systems are retrieving the brand as a meaningful candidate in the first place.

Discovery is technically the strongest cluster, but only because it contains the only surfaced mention-level activity. In the discovery cluster, Sun Genomics has a neutral visibility rate of 0.0039 and a positive visibility rate of 0. It has no valid top-three recommendations, no rank-one placements, and no captured recommendation value. Comparisons and pricing both show zeros across the board in the surfaced packet.

The competitive context is severe. In the same packet, competitors like Garden of Life, Culturelle, Florastor, Seed Health, Renew Life, and Pendulum all show measurable recommendation activity, while Sun Genomics remains at zero across the recommendation metrics that matter.

The strategic takeaway is straightforward: Sun Genomics does not yet have a public AI recommendation lane in this dataset. The immediate goal is not to optimize ranking from position three to position one. It is to become recommendation-eligible at all.

What Sun Genomics Is Winning

There is no evidence in the surfaced packet that Sun Genomics is winning any recommendation-stage lane. The strongest available readout is a very small neutral presence in discovery, not a positive recommendation pocket.

That matters because it changes the interpretation. This is not a case where Sun Genomics is visible but not preferred. It is a case where the brand is barely entering the answer set at all.

Where Sun Genomics Has the Clearest AI Visibility Gaps

The biggest gap is retrieval into discovery. In C01 discovery, Sun Genomics shows only neutral visibility and no positive visibility, no top-three placements, and no modeled captured value. If a brand cannot enter discovery shortlists, it cannot realistically compete in later-stage comparison or pricing prompts.

The next gap is total absence from comparisons. In C02, Sun Genomics records zero neutral visibility, zero positive visibility, zero rank activity, and zero captured value, while Pendulum is the surfaced winner in that cluster.

Pricing is equally weak. In C03, Sun Genomics again records zeros across recommendation metrics, while Culturelle is the surfaced winner. That means Sun Genomics is not present even in evaluation-stage or cost-stage buyer prompts where other brands are already capturing recommendation share.

Biggest Opportunity

The biggest opportunity is to build a recognizable, recommendation-eligible public narrative around a clear use case before trying to compete broadly. The packet suggests Sun Genomics currently lacks the citation density, entity clarity, or prompt-lane ownership needed to enter AI shortlists. The first objective should be to become retrievable and positively framed in one discovery lane, then expand outward into comparison and pricing prompts later.

Prompt Evidence

The surfaced packet did not return Sun Genomics-specific positive prompt examples. That is itself part of the finding.

**Packet-level readout / Best Probiotics Discovery ** Prompt set: **broad discovery prompts in C01 ** Result: Sun Genomics records only neutral discovery visibility at 0.0039, with zero positive visibility, zero top-three recommendations, and zero captured recommendation value.

**Packet-level readout / Probiotic Comparisons ** Prompt set: **head-to-head evaluation prompts in C02 ** Result: Sun Genomics records zero positive or neutral visibility, zero rank activity, and zero captured value.

**Packet-level readout / Probiotic Pricing Research ** Prompt set: **pricing prompts in C03 ** Result: Sun Genomics records zero presence and zero captured value, while Culturelle is the surfaced cluster winner.

What CiteWorks Studio Would Do Next

**Phase 1: AI Market Discovery Audit ** Map whether Sun Genomics is disappearing because of weak public entity signals, weak citation support, or weak alignment to the tracked prompt market. The current packet suggests the brand is not entering the answer set reliably.

**Phase 2: Recommendation Readiness Plan ** Choose one or two discovery-stage prompt lanes where Sun Genomics can plausibly compete, then define the evidence and framing needed for recommendation eligibility there first.

**Phase 3: Owned Answer Layer Buildout ** Build clearer use-case pages, comparison pages, and explanation pages that make it easier for AI systems to understand what Sun Genomics is for and when it should be considered.

**Phase 4: Citation / Authority Layer Development ** Strengthen the public source layer around the chosen prompt lanes so AI systems have enough third-party and structured support to retrieve Sun Genomics as a credible option.

**Phase 5: Monthly AI Visibility and Recommendation Tracking ** Track first appearance, positive visibility, valid recommendation coverage, and top-three movement separately. For Sun Genomics, early progress will begin with retrieval and positive framing, not just ranking gains.

Why This Matters

Sun Genomics is not yet competing on the same AI-discovery field as the category leaders in this packet. That is important because AI-mediated buyer choice tends to compress categories into a shortlist. Brands that do not enter that shortlist are functionally invisible at the recommendation stage.

For Sun Genomics, the next move is not generic awareness work. It is targeted correction of the prompt, page, and citation layers that determine whether the brand becomes recommendation-eligible at all.

Core Metrics

• Mentions: 0 in the surfaced company-level packet summary
• Valid recommendations: 0
• Top 3 recommendation count: 0
• Rank #1 recommendation count: 0
• Average recommended rank: null
• Positive mentions: 0
• Neutral mentions: 0 in the surfaced overall packet summary
• Negative mentions: 0
• Raw mention presence rate: 0
• Valid recommendation coverage: 0
• Top 3 recommendation rate: 0
• Rank #1 recommendation rate: 0
• Monthly captured recommendation value: 0.

Sentiment Score

Sentiment Score = (positive mentions × 1 + neutral mentions × 0 + negative mentions × -1) / total mentions

For Sun Genomics, the surfaced overall company metrics return a sentiment score of 0. This is less about negative framing and more about absence. Share of voice alone is a weak KPI, but Sun Genomics has an even earlier problem: there is almost no recommendation-stage visibility to classify. Presence must come before preference.

Sentiment by Platform

The retrieved Sun Genomics chunks did not surface a full platform-by-platform table. The defensible readout is that the company has no surfaced positive recommendation behavior in the packet and only a tiny neutral footprint in discovery-related slices.

Methodology Note

This is a company-specific public report for Sun Genomics based on the May 2026 gut health and probiotics packet. One QA note matters: some downstream cluster labels still carry inherited template language, so cluster names here are normalized to Best Probiotics Discovery, Probiotic Comparisons, and Probiotic Pricing Research using the packet’s stage and intent structure. The much larger takeaway, though, is that the surfaced Sun Genomics packet contains almost no recommendation-stage signal.

Methodology

• This is a one-company report. Sun Genomics is the target company, and the other named brands are treated as competitors relative to Sun Genomics.
• The reporting window is May 2026. The structured dataset is marked report month 2026-05 and was extracted on May 20, 2026.
• The packet covers six AI platforms: ChatGPT, Gemini, Perplexity, Copilot, Google AI Mode, and Google AI Overviews.
• The public packet contains 642 AI observations across 479 unique prompt texts. That is the denominator used for overall rates in this report.
• The tracked brand set includes Align Probiotics, Arrae, Bio-Kult, Culturelle, Florastor, Garden of Life, Pendulum, Renew Life, Seed Health, and Sun Genomics.
• The public clusters used are Best Probiotics Discovery, Probiotic Comparisons, and Probiotic Pricing Research.
• A mention counts whenever the company appears in an AI answer, whether as a factual reference, comparison anchor, cited entity, product example, or recommendation candidate.
• A valid recommendation requires positive shortlist-quality recommendation framing. Neutral factual references, comparison-only mentions, cautionary answers, and fallback records do not receive full recommendation credit.
• Recommendation quality is evaluated using raw mention presence, valid recommendation coverage, top-three rate, rank-one rate, average recommended rank, sentiment/framing, and modeled captured recommendation value.
• This is a point-in-time benchmark. AI outputs can change with prompt wording, platform updates, retrieval state, and source changes. The retrieved Sun Genomics packet did not surface platform splits and showed almost no company-level recommendation activity, so this report is necessarily constrained by the available public signal.